Stock comparison
United Therapeutics
West Pharmaceutical Services
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
WST
West Pharmaceutical Services
Market cap
$22.35B
Sector
Healthcare
Overall winner
United Therapeutics UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | UTHR | WST | Winner |
|---|---|---|---|
| Warren Buffett | 71B | 58C | UTHR |
| Benjamin Graham | 76B | 88A | WST |
| Philip Fisher | 76B | 47D | UTHR |
| Peter Lynch | 62C | 24F | UTHR |
| Joel Greenblatt | 46D | 60C | WST |
| Charlie Munger | 64C | 60C | UTHR |
| Terry Smith | 64C | 54C | UTHR |
Side-by-side metrics
| Metric | UTHR | WST |
|---|---|---|
| Market cap | $24.13B | $22.35B |
| P/E (TTM) | 19.2x | 39.8x |
| EV/EBIT | 15.2x | 34.0x |
| ROIC (TTM) | 18.81% | 15.24% |
| Gross margin | 86.58% | 36.24% |
| Net margin | 40.61% | 16.85% |
| Revenue CAGR 5y | 17.22% | 2.08% |
| EPS CAGR 5y | 29.84% | -6.4% |
| Debt / Equity | - | 0.1x |
| Dividend yield | 0.0% | 0.29% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
UTHR leads on
- EPS CAGR 5y29.84%vs -6.4%+121%
- Debt / Equity-vs 0.1x+100%
- Revenue CAGR 5y17.22%vs 2.08%+88%
- Net margin40.61%vs 16.85%+59%
WST leads on
- Dividend yield0.29%vs 0.0%+100%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.